Puranik Gururaj N, Verma Tanvi Y P, Pandit Gopal A
Dr. V.M. Government Medical College, Solapur, India.
J Hematol. 2018 Sep;7(3):107-111. doi: 10.14740/jh432w. Epub 2018 Sep 1.
Mortality from trauma remains a major public health issue as it is the leading cause of death in persons aged 5 - 44 years. There is a dearth of information on polytrauma from developing countries such as ours. Hence, this topic was studied at our institute. The objective is to study the coagulation parameters in polytrauma patients at our institute and to correlate the findings with the prognosis.
A prospective study was carried out in the department of pathology in a tertiary care center, during a period of 20 months from December 2012 to July 2014. All the polytrauma patients (injury severity score (ISS) ≥ 15) with injuries to head and neck, face, thorax, abdomen, extremities and external (skin) were included. Sampling was done within 20 min of arrival during primary survey of the patient. Screening tests like bleeding time (BT) and clotting time (CT) were carried out bedside. Other tests carried out were complete blood count (CBC), prothrombin time (PT), activated thromboplastin time (aPTT), thrombin time (TT) and D-dimer assay. Tests were carried out on fresh samples within 2 h of collection.
The incidence of coagulopathy was 59.86%. There was significant prolongation of PT, aPTT and TT in those patients who developed coagulopathy. PT was found to be a stronger predictor of mortality among polytrauma patients.
A significant proportion of polytrauma patients were coagulopathic. Initial coagulation profile is very useful in predicting outcomes for major polytrauma patients. This study emphasizes the importance of early suspicion and basic screening for coagulopathy in polytrauma patients in developing countries.
创伤导致的死亡率仍然是一个重大的公共卫生问题,因为它是5至44岁人群死亡的主要原因。像我们这样的发展中国家,关于多发伤的信息匮乏。因此,我们研究所对这一课题进行了研究。目的是研究我们研究所多发伤患者的凝血参数,并将研究结果与预后相关联。
在一家三级医疗中心的病理科进行了一项前瞻性研究,时间跨度为2012年12月至2014年7月的20个月。纳入所有头部、颈部、面部、胸部、腹部、四肢及体表(皮肤)受伤的多发伤患者(损伤严重度评分(ISS)≥15)。在对患者进行初次检查的20分钟内进行采样。床边进行出血时间(BT)和凝血时间(CT)等筛查试验。还进行了其他检查,包括全血细胞计数(CBC)、凝血酶原时间(PT)、活化部分凝血活酶时间(aPTT)、凝血酶时间(TT)和D - 二聚体检测。在采集后2小时内对新鲜样本进行检测。
凝血病的发生率为59.86%。发生凝血病的患者PT、aPTT和TT显著延长。发现PT是多发伤患者死亡率更强的预测指标。
相当一部分多发伤患者存在凝血病。初始凝血指标对预测严重多发伤患者的预后非常有用。本研究强调了在发展中国家对多发伤患者早期怀疑和进行凝血病基本筛查的重要性。